About
Stent design and technology
Areas of Focus
Categories
Medical ImplantMiddle East
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
15
As Collaborator
1
Total Enrollment
3,411
By Phase
NA: 11PHASE2: 1PHASE4: 1
By Status
COMPLETED: 11SUSPENDED: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06071702Lead Sponsor
IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
NASuspended
30 participants
Started: Aug 7, 2025 · Completed: Aug 10, 2026
NCT06410313Lead Sponsor
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
NARecruiting
30 participants
Started: Aug 15, 2024 · Completed: Feb 28, 2030
NCT05364697Lead Sponsor
IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
NAActive, not recruiting
60 participants
Started: Aug 30, 2022 · Completed: Dec 31, 2029
NCT04761939Lead Sponsor
BIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) in Coronary Stenosis Trial
N/ACompleted
81 participants
Started: Dec 31, 2020 · Completed: Feb 20, 2022
NCT03775226Lead Sponsor
ChampioNIR® SFA Stent EFS Study
NATerminated
22 participants
Started: Oct 27, 2019 · Completed: Jan 30, 2023
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...